{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:31Z","timestamp":1786119691417,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Clinical Psychopharmacology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/yic.0b013e3283466657","type":"journal-article","created":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T02:43:54Z","timestamp":1301539434000},"page":"221-224","source":"Crossref","is-referenced-by-count":22,"title":["Pregabalin augmentation in treatment-resistant obsessive\u2013compulsive disorder"],"prefix":"10.1097","volume":"26","author":[{"given":"Panagiotis","family":"Oulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraklis","family":"Mourikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Konstantakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["International Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004850-201107000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:56:22Z","timestamp":1786042582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004850-201107000-00006"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":0,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1097\/yic.0b013e3283466657","relation":{},"ISSN":["0268-1315"],"issn-type":[{"value":"0268-1315","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}